BackBlackRock Health Sciences Term Trust Overview
BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust Price to Sales

Latest P/S ratio for BlackRock Health Sciences Term Trust: 3.36 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Price to Sales

3.36

Price to Sales

3.36

Price-to-Sales ratio compares a company's stock price to its revenue per share. A lower P/S ratio may indicate that the stock is undervalued relative to its sales.

Price to Sales (Comparison Companies)

Loading

Price to Sales History

Loading

Price to Sales Comparison

Loading

BlackRock Health Sciences Term Trust (BMEZ) FAQ

As of the most recent data, BMEZ shows a P/S ratio of 3.36. That is below the sector sector average of 11.28. Scroll down for historical charts and peer comparison views.

The its sector sector average P/S ratio is about 11.28. BlackRock Health Sciences Term Trust is at 3.36, which is lower that average. That is roughly 70.2% below the sector mean. Use the comparison chart on this page to see how BMEZ stacks up against individual peers as well.

Investors watch BMEZ's P/S ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. BlackRock Health Sciences Term Trust's latest reading is 3.36. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this price-to-sales ratio page, Stockcircle has BlackRock Health Sciences Term Trust's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/S ratio (currently 3.36) with ownership activity and broader fundamentals.